Olanzapine and cocaine consumption in methadone maintenance programs: New results;Olanzapina y consumo de cocaína en programas de mantenimiento con metadona: Nuevos resultados

Psiquiatria Biologica

Volumn 10, Issue 5, 2003, Pages 160-164

  Landabaso, M ^a   Iraurgi Castillo, I ^b,g   Jimenez Lerma J M ^c   Hormaechea, J A ^d   Sanz, J ^a   Larrazabal, A ^e   Aizpuru, A ^a   Gutierrez Fraile M ^f  

^a Ctro Drogodependencias de Baracaldo   (Spain)

^b MAPS Rekalde   (Spain)

^c CTT   (Spain)

^d AITA   (Spain)

^e CSM Rentería   (Spain)

^f HOSPITAL DE CRUCES   (Spain)

^g Modulo de Asistencia Psicosocial de Rekalde   (Spain)

Author keywords

Cocaine consumption; Latin square; Methadone maintenance program; Olanzapine

Indexed keywords

COCAINE; METHADONE; OLANZAPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; DRUG DOSE REGIMEN; DRUG USE; FEMALE; HUMAN; IMMUNOASSAY; LATIN SQUARE DESIGN; MALE; METHADONE TREATMENT; OUTCOMES RESEARCH; URINALYSIS;

EID: 0842327445     PISSN: 01047787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Timms FM, Ludford JP, editors. Drug abuse treatment evaluation: strategies, progress and prospects. NIDA Research Monograph, 51. Mariland: National Institute on Drug Abuse, Department of Health and Human Sciences, 1989.
2. USGAO (United States General Accounting Office). Methadone maintenance: some treatment programs are not effective. Washington DC: Greater Federal Oversight Needed, 1990.
3. Ball JC, Ross A. The effectiveness of methadone maintenance treatment: patients programs, services and outcomes. New York: Springer-Verlag, 1991.
4. Condelli WS, Fairbank JA, Dennis ML, Rachal JV. Cocaine use by clients in methadone programs: significance, scope and behavioural interventions. J Substance Abuse Treat 1991;8:203-12.
5. Chatham LR, Rowan-Szal GA, Joe GW, Brown BS, Simpson DD. Heavy drinking in a population of methadone maintenance clients. J Studies Alcohol 1995;56:417-22.
6. Gossop M, Marsden J, Edwards C, Lehmann P, Wilson A, Segar G. The national treatment outcome research study in the United Kingdom: six month follow-up outcomes. Psychol Addict Behav 1997;11:324-37.
7. Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet 1999;353:221-6.
8. Chutuape MA, Silverman K, Stitzer ML. Effects of urine testing frequency on outcome in a methadone take-home contingency program. Drug Alcohol Depend 2001;62:69-76.
9. Pérez P, Calatayud G. Control de orina del uso de drogas en los centros municipales de Madrid. Adicciones 1993;5:237-46.
10. Markez I, Pinilla E, Aizpuru A. Control de drogas en orina: incidencia y utilidad en programas de mantenimiento con metadona. Adicciones 1998;10:131-7.
11. Fernández-Miranda JJ, González-Portilla MP, Saiz-Martínez PA, Gutiérrez-Cienfuegos E, Bobes J. Consumo de drogas ilegales y alcohol antes y a lo largo de 6 años de mantenimiento con metadona y variables relacionadas. Adicciones 2001;13,179-88.
12. Iraurgi I, Aizpuru A, Pinilla E, Marcos JJ, Unda J, Ormaetxea B, et al. Consumo de sustancias durante un programa de mantenimiento con metadona. Psiquiatría Biológica 2002;9,10915.
13. American Psychiatric Association Practice Guideliness. Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. Am J Psychiatry 1995;152(Suppl):11.
14. Fernández-Miranda JJ, Marina PA, editors. Manual de los tratamientos de mantenimiento con opiáceos. Oviedo: Gráficas Papiro, 1999.
15. Duntemant GH, Condelli WS, Fairbank JA. Predictins cocaine use among methadone patients: analysis of findings from a national study. Hosp Community Psychol 1992;43:608-11.
16. Iraurgi I, Casas A. Factores asociados al consumo de sustancias en un programa de mantenimiento con metadona. Rev Esp Drogodependencias 1999;24:389-400.
17. Hartel DM, Schoenbaum EE, Selwyn PA, Kline J, Davenny K, Klein RS, et al. Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health 1995;85:83-8.
18. Kidorf M, Stitzer ML. Descriptive analysis of cocaine use of methadone patients. Drug Alcohol Dependence 1993;32:267-75.
19. Caplehorn JRM, Bell J, Kleinbaum DG, Gebski VJ. Methadone dose and heroin use during maintenance treatment. Addiction 1993;88:119-24.
20. Stitzer ML, Bickel WK, Bigelow GE, Liebson IA. Effect of methadone dose contingencies on urinalysis test results of polydrug-abusing methadone-maintenance patients. Drug Alcohol Depend 1986;18:341-8.
21. Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Dose-response effects of methadone in treatment of opioid dependence. Ann Inter Med 1993;119:23-7.
22. Landabaso M, Casete L, Díaz-González T, Sanz J, Terán A. Cocaína y otros estimulantes. En: Ferná ndez-Mirada JJ, Gutiérrez-Cienfuegos E, Marina PA, editores. Actuaciones clínicas en trastornos adictivos. Madrid: Aula Médica, 2002; p. 337-74.
23. Landabaso M, Iraurgi I, Jiménez-Lerma JM, Sanz J, Calle R, Larrazabal A, et al. Olanzapina y consumo de cocaína en programa de mantenimiento con metadona. Psiq Biol 2001;8:171-4.
24. Deam AM, Voss D. Design and analysis of experiments. New York: Springer-Verlag, 1998.
25. Washington State University. A field guide to experimental designs. [Consultado el 10/01/2003]. Disponible en: http://www.tfrec.wsu.edu/ANOVA/index.html
26. Hawks RL, Chiang CN. Urine testing for drug of abuse. Examples of specific drug assays. Research Monograph 73. National Institute on Drug Abuse. Mariland: Department of Health and Human Sciences, 1986.
27. McCarthy J. Quantitative urine drug monitoring in methadone programs: Potential clinical uses. J Psychoactives Drugs 1994;26:199-206.
28. Norusis MJ. Statistical package for the social sciences. Release 10. Chicago: SPSS Inc., 1999.
29. Edwards AL. Experimental design in psychological research. 5th ed. New York: Holt, Rinehart and Winston, 1985.
30. Fulton B, Goa KL. Olanzapine. Drugs 1997;53:281-98.
31. Callado LF, Meana JJ. Neurolépticos atípicos y consumo de sustancias, bases farmacológicas. Trastornos Adictivos 2001;3:7-18.